In type 2 diabetes (T2D), insulin-resistant cells like adipocytes and myocytes release EVs containing abnormally expressed miRNAs, which in turn may disrupt insulin signaling mechanisms in recipient cells (7). Here, INS is linked to type 2 diabetes mellitus.